CN1679795A - Anti-tumor extract of salicymus root and its preparation method and use - Google Patents
Anti-tumor extract of salicymus root and its preparation method and use Download PDFInfo
- Publication number
- CN1679795A CN1679795A CN 200510032665 CN200510032665A CN1679795A CN 1679795 A CN1679795 A CN 1679795A CN 200510032665 CN200510032665 CN 200510032665 CN 200510032665 A CN200510032665 A CN 200510032665A CN 1679795 A CN1679795 A CN 1679795A
- Authority
- CN
- China
- Prior art keywords
- extract
- root
- tumor
- salicymus
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 74
- 230000000259 anti-tumor effect Effects 0.000 title claims description 44
- 238000002360 preparation method Methods 0.000 title claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 5
- 239000007924 injection Substances 0.000 claims abstract description 4
- 238000002347 injection Methods 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 17
- 239000006228 supernatant Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims description 13
- 229960001860 salicylate Drugs 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 8
- 235000008375 Decussocarpus nagi Nutrition 0.000 claims description 5
- 244000132436 Myrica rubra Species 0.000 claims description 5
- 235000014631 Myrica rubra Nutrition 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical group O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 5
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 claims description 5
- 235000009134 Myrica cerifera Nutrition 0.000 claims description 4
- 244000061457 Solanum nigrum Species 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 241000682719 Adina Species 0.000 abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 230000003311 flocculating effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 description 11
- 238000001556 precipitation Methods 0.000 description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- -1 salicyrin A Natural products 0.000 description 5
- PDKKRUPVSFVVFM-UHFFFAOYSA-N Chinovinsaeure Natural products CC1(C)CCC2(C)CCC3(C4CCC5C(C)(C)C(O)CCC5(C(=O)O)C4=CCC3C2(C)C1)C(=O)O PDKKRUPVSFVVFM-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000219433 Myrica Species 0.000 description 2
- 239000012675 alcoholic extract Substances 0.000 description 2
- 239000008394 flocculating agent Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000682731 Adina rubella Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 235000021513 Cinchona Nutrition 0.000 description 1
- 241000157855 Cinchona Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical group ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000605411 Lloydia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域Technical field
本发明涉及医药领域,特别涉及一种水杨梅根抗肿瘤提取物及其制备方法和用途。The present invention relates to the field of medicine, in particular to an anti-tumor extract of salicybean root and its preparation method and application.
背景技术 Background technique
水杨梅根为茜草科落叶灌木植物水杨梅(Adina rubella(Sieb.etZucc.)Hance)的根,具有清热解毒、散淤止痛之功效。郁仁存等人在“肿瘤常用中草药”,中医肿瘤学,1997,72页中报道,水杨梅根醇浸膏每日以5g/Kg连续灌胃或腹腔注射6天,对小鼠白血病L615有抑制作用,抑制率为21.4%;对小鼠宫颈癌细胞、小白鼠肉瘤AK、及大白鼠肉瘤均有抑制作用;这提示水杨梅根醇浸膏有广谱抗肿瘤作用。水杨梅的花果序中含儿茶素类化合物,另有熊果酸、齐墩果酸、β-谷甾醇、水杨梅甲素及生物碱等,但关于水杨梅根的有效成分报道较少。何直升等人在“水杨梅化学成分的研究”,中草药,1996,26(6):285~288中报道,他们从水杨梅根中分离出数种新的Quinovic acid糖苷化合物,但未进行抗肿瘤活性研究。Quinovic acid糖苷在其它抗肿瘤植物中也被发现,曾有文献Raffauf RF,etal.Lloydia,1978,41(5):432~434提及,在金鸡纳树皮中发现了Quinovic acid糖苷化合物,该化合物具有抗肿瘤活性,后来Raffauf RF在其它具有抗肿瘤活性的植物药材中也发现了此类化合物,这表明Quinovic acid糖苷化合物有可能也是水杨梅根的主要抗肿瘤活性物质。The root of Myrica rubella is the root of Adina rubella (Sieb. et Zucc.) Hance, a deciduous shrub of the Rubiaceae family. Yu Rencun et al. reported in "Common Chinese Herbal Medicine for Tumors", Oncology of Traditional Chinese Medicine, 1997, page 72, that salicylic radix root alcoholic extract was administered orally or intraperitoneally at 5g/Kg daily for 6 days, and it had inhibitory effect on mouse leukemia L615 , and the inhibition rate was 21.4%; it had inhibitory effects on mouse cervical cancer cells, mouse sarcoma AK, and rat sarcoma; this suggested that the alcoholic extract of Salicymus root had a broad-spectrum anti-tumor effect. The inflorescences of Myrica salicifolia contain catechins, ursolic acid, oleanolic acid, β-sitosterol, salicyrin A, and alkaloids, etc., but there are few reports on the effective components of Myrica rubra root . He Zhisheng and others reported in "Research on the Chemical Constituents of Myrica rubra", Chinese Herbal Medicine, 1996, 26(6): 285-288, that they isolated several new Quinovic acid glycoside compounds from the root of Myrica rubra, but did not carry out Antitumor activity studies. Quinovic acid glycosides are also found in other anti-tumor plants. It was mentioned in the literature Raffauf RF, etal.Lloydia, 1978, 41 (5): 432-434 that Quinovic acid glycosides were found in cinchona bark. The compound has anti-tumor activity, and later Raffauf RF also found this kind of compound in other plant medicinal materials with anti-tumor activity, which indicates that Quinovic acid glycoside compound may also be the main anti-tumor active substance of salicymus root.
目前,对水杨梅根的研究仅停留在其药材的粗浅认识上,没有关于水杨梅根抗肿瘤有效部位和成分分离方法、制剂技术的报道。At present, the research on the root of salicylum only stays in the superficial understanding of its medicinal materials, and there are no reports on the anti-tumor effective parts, component separation methods and preparation techniques of the root of salicylate.
发明内容Contents of Invention
本发明的目的在于克服现有技术中存在的缺点,提供一种可有效地纯化中药水杨梅根的有效部位,便于工业化生产的水杨梅根抗肿瘤提取物制备方法。The purpose of the present invention is to overcome the shortcomings in the prior art, and to provide a method for preparing the anti-tumor extract of salicylum root which can effectively purify the effective part of the traditional Chinese medicine salicylaceae root and is convenient for industrial production.
本发明的另一目的在于提供一种由上述方法制备的水杨梅根抗肿瘤提取物。Another object of the present invention is to provide an anti-tumor extract of salicyrdium root prepared by the above method.
本发明的再一目的在于提供一种上述水杨梅根抗肿瘤提取物的用途。Another object of the present invention is to provide a use of the anti-tumor extract of the above-mentioned salicylic bayberry root.
本发明的目的通过下述技术方案实现:本水杨梅根抗肿瘤提取物的制备方法包括下述步骤:The object of the present invention is achieved through the following technical scheme: the preparation method of the anti-tumor extract of the salicymus root comprises the following steps:
(1)用水或有机溶剂在70~100℃温度下浸提水杨梅根药材,得到浸出液;(1) extracting the root medicinal material of Myrica rubra with water or an organic solvent at a temperature of 70-100° C. to obtain an extract;
(2)在浸出液中加入絮凝剂,沉淀去杂,得到提取液;(2) Adding a flocculant to the leaching solution to precipitate and remove impurities to obtain an extract;
(3)将提取液的pH值调节至2~5,静置,取得上清液;(3) Adjust the pH value of the extract to 2-5, let stand, and obtain the supernatant;
(4)将上清液过大孔树脂,用溶剂洗脱,收集洗脱液;(4) passing the supernatant through a macroporous resin, eluting with a solvent, and collecting the eluate;
(5)将洗脱液回收溶剂后,用乙酸乙酯萃取,得到萃取液;(5) After recovering the solvent from the eluent, extract it with ethyl acetate to obtain an extract;
(6)将萃取液浓缩干燥,得到水杨梅根抗肿瘤提取物。(6) Concentrate and dry the extract to obtain the anti-tumor extract of the salicylate root.
步骤(1)中,所述有机溶剂为30~70%(V/V)乙醇;所述水杨梅根药材可为水杨梅根块状物或粉碎物;所述浸提温度优选70~80℃。In the step (1), the organic solvent is 30-70% (V/V) ethanol; the medicinal material of salicylum root can be block or pulverized; the extraction temperature is preferably 70-80°C .
步骤(1)中,所述浸提次数为1~3次;每次浸提时间为1~2小时;第一次浸提的水杨梅根与水或有机溶剂的重量比为1∶8~10;第二次和第三次浸提的水杨梅根与水或有机溶剂的重量比为1∶4~5。In step (1), the number of extractions is 1 to 3 times; each extraction time is 1 to 2 hours; the weight ratio of the root of the salicymus root extracted for the first time to water or organic solvent is 1: 8~ 10: The weight ratio of the salicylate root extracted for the second and third times to water or organic solvent is 1:4-5.
步骤(2)中,可将浸出液先浓缩,然后再絮凝沉淀;所述絮凝剂可为甲壳素、ZTC絮凝剂或明胶,用量为水杨梅根药材重量的0.1~1%;所述沉淀可采用过滤或离心分离沉淀。In step (2), the leachate can be concentrated first, and then flocculated and precipitated; the flocculating agent can be chitin, ZTC flocculating agent or gelatin, and the dosage is 0.1 to 1% of the weight of the root medicinal material of salicymus; Filter or centrifuge the precipitate.
步骤(3)中,采用酸性试剂来调节提取液的pH值,优选盐酸、醋酸。In step (3), an acidic reagent is used to adjust the pH value of the extract, preferably hydrochloric acid or acetic acid.
步骤(4)中,所述大孔树脂可为各种非极性或弱极性的大孔树脂;所述溶剂为含水溶剂,优选乙醇水或丙酮水。In step (4), the macroporous resin can be various nonpolar or weakly polar macroporous resins; the solvent is an aqueous solvent, preferably ethanol water or acetone water.
步骤(5)中,所述乙酸乙酯的用量为洗脱液的1~3倍体积量。In step (5), the amount of ethyl acetate used is 1 to 3 times the volume of the eluent.
步骤(6)中,所述干燥可为真空干燥、喷雾干燥或冷冻干燥。In step (6), the drying may be vacuum drying, spray drying or freeze drying.
采用上述方法制备得到水杨梅根抗肿瘤提取物;所制备的水杨梅根抗肿瘤提取物有效成分(多酚类)含量可达80~90%。The above-mentioned method is used to prepare the anti-tumor extract of the salicylic root; the active ingredient (polyphenols) content of the prepared anti-tumor extract can reach 80-90%.
该水杨梅根抗肿瘤提取物作为活性成分与可接受的药物载体结合制成可用于治疗各种肿瘤的口服或注射单方以及复方制剂,如以淀粉等为辅料制成的片剂、以微晶纤维素为辅料制成的胶囊剂、以甘露醇为支架制成的注射剂等。The anti-tumor extract of salicymus root is used as an active ingredient in combination with an acceptable drug carrier to make oral or injection single and compound preparations that can be used to treat various tumors, such as tablets made with starch and other auxiliary materials, microcrystalline Capsules made of cellulose as auxiliary materials, injections made of mannitol as a scaffold, etc.
本发明与现有技术相比具有如下优点和效果:Compared with the prior art, the present invention has the following advantages and effects:
(1)本发明对原料药材采用高温、多次、长时间浸提,浸提效果好,原料药材中抗肿瘤有效成分转移率高;(1) The present invention adopts high temperature, multiple times, and long-time leaching to the raw medicinal material, and the extraction effect is good, and the transfer rate of the anti-tumor active ingredients in the raw medicinal material is high;
(2)工艺简单,沉淀步骤采用了絮凝沉淀法,可避免醇沉法的因沉淀不完全而造成的损失和乙醇回收而增加的工艺步骤;(2) The process is simple, and the precipitation step adopts the flocculation precipitation method, which can avoid the loss caused by incomplete precipitation and the increased process steps of ethanol recovery in the alcohol precipitation method;
(3)产品纯度高,便于工业化生产,一方面采用调酸法除去酸不溶物,提高大孔树脂的吸附效果;另一方面采用大孔树脂纯化水杨梅根抗肿瘤的有效部位,并采用乙酸乙酯萃取法进一步提高有效部位的纯度,提高有效成分含量和精度。(3) product purity is high, is convenient to suitability for industrialized production, adopts acid adjustment method to remove acid-insoluble matter on the one hand, improves the adsorption effect of macroporous resin; The ethyl ester extraction method further improves the purity of the effective parts, and improves the content and precision of the active ingredients.
具体实施方式 Detailed ways
下面结合实施例对本发明做进一步详细的描述,但本发明的实施方式不限于此。The present invention will be described in further detail below in conjunction with the examples, but the embodiments of the present invention are not limited thereto.
实施例1Example 1
将1Kg的水杨梅根药材,加入10L的水,保持在100℃温度下浸提120分钟,然后过滤得到第一次浸出液;再在滤渣中加入5L的水,保持在100℃温度下浸提90分钟,然后过滤得到第二次浸出液;合并两次浸出液。Add 10L of water to 1Kg of salicylum root medicinal material, keep it at 100°C for 120 minutes, and then filter to obtain the first leachate; then add 5L of water to the filter residue, keep it at 100°C for 90 minutes Minutes, then filter to obtain the second leachate; combine the two leachates.
将浸出液减压浓缩至热比重为1.05,加入甲壳素1g,搅拌后离心去沉淀,得到提取液;用10%盐酸将提取液的pH值调至2,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂D101,然后用70%乙醇水洗脱,再将洗脱液减压回收乙醇,然后用1倍体积量的乙酸乙酯萃取3次;最后将萃取液常压浓缩、真空干燥,制得30g的水杨梅根抗肿瘤提取物。经测定其多酚含量为85%。Concentrate the leachate under reduced pressure until the thermal specific gravity is 1.05, add 1g of chitin, centrifuge to remove the precipitate after stirring, and obtain the extract; adjust the pH value of the extract to 2 with 10% hydrochloric acid, then let it stand, and centrifuge to remove the precipitate, and obtain the above supernatant; the supernatant was passed through the macroporous resin D101, then eluted with 70% ethanol water, and then the eluate was decompressed to recover ethanol, and then extracted 3 times with 1 times the volume of ethyl acetate; finally the extract Concentrate under normal pressure and dry in vacuum to prepare 30 g of the anti-tumor extract of the salicylate root. Its polyphenol content is determined to be 85%.
实施例2Example 2
将1Kg的水杨梅根药材粉碎成粗粉,加入8L的水,保持在80℃温度下浸提60分钟,然后过滤得到第一次浸出液;再在滤渣中加入4L的水,保持在80℃温度下浸提60分钟,然后过滤得到第二次浸出液;合并两次浸出液。Grind 1Kg of salicylate root medicinal material into coarse powder, add 8L of water, keep at 80°C for 60 minutes, then filter to obtain the first leachate; then add 4L of water to the filter residue, keep at 80°C Under leaching for 60 minutes, and then filtered to obtain the second leaching solution; the two leaching solutions were combined.
将浸出液加入明胶10g,搅拌后离心去沉淀,得到提取液;用20%醋酸将提取液的pH值调至5,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂HPD300,然后用70%丙酮水洗脱,再将洗脱液减压回收丙酮,然后用3倍体积量的乙酸乙酯萃取1次;最后将萃取液减压浓缩、冷冻干燥,制得35g的水杨梅根抗肿瘤提取物。经测定其多酚含量为87%。Add 10g of gelatin to the leachate, stir and centrifuge to remove the precipitate to obtain the extract; use 20% acetic acid to adjust the pH value of the extract to 5, then let it stand and centrifuge to remove the precipitate to obtain the supernatant; pass the supernatant through the large hole Resin HPD300, then eluted with 70% acetone water, then the eluent was decompressed to recover acetone, and then extracted once with 3 times the volume of ethyl acetate; finally, the extract was concentrated under reduced pressure and freeze-dried to obtain 35g Antineoplastic extract of salicylate root. Its polyphenol content is determined to be 87%.
实施例3Example 3
将1Kg的水杨梅根药材粉碎成粗粉,加入9L的水,保持在90℃温度下浸提90分钟,然后过滤得到第一次浸出液;再在滤渣中加入5L的水,保持在90℃温度下浸提90分钟,然后过滤得到第二次浸出液;再在滤渣中加入5L的水,保持在90℃温度下浸提90分钟,然后过滤得到第三次浸出液;合并三次浸出液。Grind 1Kg of salicylate root medicinal material into coarse powder, add 9L of water, keep at 90°C for 90 minutes, then filter to obtain the first leachate; then add 5L of water to the filter residue, keep at 90°C Extract at low temperature for 90 minutes, then filter to obtain the second leach solution; then add 5 L of water to the filter residue, keep it at 90°C for 90 minutes, then filter to obtain the third leach solution; combine the three leach solutions.
将浸出液常压浓缩至热比重1.03,加入ZTC絮凝剂3g,搅拌后离心去沉淀,得到提取液;用5%盐酸将提取液的pH值调至3,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂HPD600,然后用50%丙酮水洗脱,再将洗脱液减压回收丙酮,然后用2倍体积量的乙酸乙酯萃取3次;最后将萃取液常压浓缩、喷雾干燥,制得36g的水杨梅根抗肿瘤提取物。经测定其多酚含量为83%。Concentrate the leachate under normal pressure to a thermal specific gravity of 1.03, add 3g of ZTC flocculant, stir and centrifuge to remove the precipitate to obtain the extract; use 5% hydrochloric acid to adjust the pH value of the extract to 3, then let stand, centrifuge to remove the precipitate, and obtain the above supernatant; the supernatant was passed through the macroporous resin HPD600, then eluted with 50% acetone water, and then the eluate was decompressed to recover acetone, and then extracted 3 times with 2 times the volume of ethyl acetate; finally the extract Atmospheric pressure concentration, spray drying, prepared 36g of salicylate root anti-tumor extract. Its polyphenol content is determined to be 83%.
实施例4Example 4
将1Kg的水杨梅根药材粉碎成粗粉,加入10L的70%乙醇,保持在70℃温度下浸提90分钟,然后过滤得到第一次浸出液;再在滤渣中加入5L的70%乙醇,保持在70℃温度下浸提60分钟,然后过滤得到第二次浸出液;合并两次浸出液。The root medical material of salicymus root of 1Kg is pulverized into coarse powder, adds 70% ethanol of 10L, keeps leaching 90 minutes at 70 ℃ of temperature, then filters and obtains the leachate for the first time; Leach at a temperature of 70°C for 60 minutes, and then filter to obtain a second leach solution; combine the two leach solutions.
将浸出液减压浓缩至热比重1.05,加入甲壳素3g,搅拌后离心去沉淀,得到提取液;用5%盐酸将提取液的pH值调至2,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂HPD300,然后用50%乙醇水洗脱,再将洗脱液减压回收乙醇,然后用3倍体积量的乙酸乙酯萃取2次;最后将萃取液减压浓缩、冷冻干燥,制得38g的水杨梅根抗肿瘤提取物。经测定其多酚含量为93%。Concentrate the leachate under reduced pressure to a thermal specific gravity of 1.05, add 3g of chitin, stir and centrifuge to remove the precipitate to obtain the extract; use 5% hydrochloric acid to adjust the pH value of the extract to 2, then stand still and centrifuge to remove the precipitate, and obtain the supernatant liquid; the supernatant was passed through the macroporous resin HPD300, then eluted with 50% ethanol water, and then the eluent was decompressed to reclaim ethanol, and then extracted twice with ethyl acetate of 3 times the volume; finally the extract was reduced Concentrate under pressure and freeze-dry to obtain 38g of the anti-tumor extract of the salicylate root. Its polyphenol content is determined to be 93%.
实施例5Example 5
将1Kg的水杨梅根药材粉碎成粗粉,加入8L的50%乙醇,保持在80℃温度下浸提60分钟,然后过滤得到第一次浸出液;再在滤渣中加入4L的50%乙醇,保持在80℃温度下浸提60分钟,然后过滤得到第二次浸出液;再在滤渣中加入4L的50%乙醇,保持在80℃温度下浸提60分钟,然后过滤得到第三次浸出液;合并三次浸出液。The root medical material of salicymus root of 1Kg is pulverized into coarse powder, adds 50% ethanol of 8L, keeps leaching at 80 ℃ of temperature for 60 minutes, then filters to obtain the leachate for the first time; then adds 50% ethanol of 4L in filter residue, keeps Extract at 80°C for 60 minutes, then filter to obtain the second leachate; then add 4L of 50% ethanol to the filter residue, keep it at 80°C for 60 minutes, then filter to obtain the third leachate; combine three times Leachate.
将浸出液常压浓缩至热比重1.03,加入明胶8g,搅拌后离心去沉淀,得到提取液;用20%醋酸将提取液的pH值调至4,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂HPD600,然后用70%丙酮水洗脱,再将洗脱液减压回收丙酮,然后用2倍体积量的乙酸乙酯萃取2次;最后将萃取液常压浓缩、喷雾干燥,制得36g的水杨梅根抗肿瘤提取物。经测定其多酚含量为96%。Concentrate the leachate under normal pressure to a thermal specific gravity of 1.03, add 8g of gelatin, centrifuge to remove the precipitate after stirring, and obtain the extract; use 20% acetic acid to adjust the pH value of the extract to 4, then stand still, and centrifuge to remove the precipitate to obtain the supernatant ; The supernatant was passed through the macroporous resin HPD600, then eluted with 70% acetone water, and then the eluent was decompressed to reclaim acetone, and then extracted twice with 2 times the volume of ethyl acetate; finally the extract was extracted under normal pressure Concentrate and spray-dry to prepare 36 g of the anti-tumor extract of the salicylate root. Its polyphenol content is determined to be 96%.
实施例6Example 6
将1Kg的水杨梅根药材,加入9L的30%乙醇,保持在80℃温度下浸提120分钟,然后过滤得到第一次浸出液;再在滤渣中加入5L的30%乙醇,保持在80℃温度下浸提90分钟,然后过滤得到第二次浸出液;合并两次浸出液。Add 9L of 30% ethanol to 1Kg of salicylate root medicinal material, keep it at 80°C for 120 minutes, then filter to obtain the first leachate; then add 5L of 30% ethanol to the filter residue, keep at 80°C Under leaching for 90 minutes, and then filtered to obtain the second leaching solution; the two leaching solutions were combined.
在浸出液中加入ZTC絮凝剂5g,搅拌后离心去沉淀,得到提取液;用10%盐酸将提取液的pH值调至3,然后静置、离心去沉淀,取得上清液;将上清液过大孔树脂D101,然后用70%乙醇水洗脱,再将洗脱液减压回收乙醇,然后用1倍体积量的乙酸乙酯萃取3次;最后将萃取液常压浓缩、真空干燥,制得32g的水杨梅根抗肿瘤提取物。经测定其多酚含量为90%。Add 5g of ZTC flocculant to the leaching solution, centrifuge to remove precipitation after stirring, and obtain the extract; use 10% hydrochloric acid to adjust the pH value of the extract to 3, then let stand, centrifuge to remove precipitation, and obtain the supernatant; Pass through the macroporous resin D101, then elute with 70% ethanol water, then reduce the eluent to recover ethanol, then extract with 1 times the volume of ethyl acetate for 3 times; finally, concentrate the extract under normal pressure and dry it in vacuum. 32 g of the anti-tumor extract of salicylaceae root were prepared. Its polyphenol content is determined to be 90%.
实施例7Example 7
水杨梅根抗肿瘤提取物的细胞实验:Cellular experiment of anti-tumor extract of salicymus root:
方法:将肿瘤细胞(2×106/ml),放入无菌的96孔培养平板,每孔加肿瘤细胞悬液50μl,加含15%小牛血清的1640培养液50μl,加实施例1~3制备的水杨梅根抗肿瘤提取物的水溶液10μl,每组3孔,孔内加等量的生理盐水振荡混匀,然后放入5%的CO2培养箱(37℃)培养24h,加入四唑盐(MTT)磷酸缓冲液,每孔10μl(每ml含MTT5mg)继续培养4h,然后加二甲砜100ml,终止反应,用酶胶免疫检测仪,分别于波长570nm,630nm处测定光密度OD值,计算结果。Method: Put tumor cells (2×10 6 /ml) into a sterile 96-well culture plate, add 50 μl of tumor cell suspension, add 50 μl of 1640 culture solution containing 15% calf serum, add Example 1 ~3 Prepare 10 μl of the aqueous solution of the anti-tumor extract of salicymus root, add 3 wells in each group, add an equal amount of normal saline to the wells, shake and mix well, then put them in a 5% CO2 incubator (37°C) for 24 hours, add Tetrazolium salt (MTT) phosphate buffer, 10 μl per hole (each ml containing 5 mg MTT) continued to incubate for 4 hours, then add 100 ml of dimethyl sulfone to terminate the reaction, and measure the optical density at wavelengths of 570 nm and 630 nm with an enzyme gel immunoassay instrument OD value, calculation result.
计算公式:Calculation formula:
结果:在胃癌RF细胞株和直肠癌LS174T细胞株肿瘤细胞培养实验中发现,水杨梅根抗肿瘤提取物对两种肿瘤的抑制率显著高于其药材的水提取物(未经过沉淀、调酸、大孔树脂吸附和萃取的水提浓缩液),且呈剂量递增。结果见附表1。Results: In the tumor cell culture experiment of gastric cancer RF cell line and rectal cancer LS174T cell line, it was found that the anti-tumor rate of the anti-tumor extract of salicymus root was significantly higher than that of the water extract of its medicinal materials (without precipitation, acid adjustment). , macroporous resin adsorption and extraction water extract concentrate), and the dosage is increasing. The results are shown in Table 1.
附表1 水杨梅根有效部位对胃癌和大肠癌细胞的抑制实验Attached table 1 Inhibition experiment of effective fractions of salicymus root on gastric cancer and colorectal cancer cells
实施例8Example 8
水杨梅根复方有效部位抑制肿瘤的动物实验Animal Experiments on Inhibiting Tumor by the Effective Fractions of Salicylica Root Compound
方法:取小鼠S180瘤块,匀浆后稀释并调整细胞数(1×107/ml),以0.2ml注入小鼠右腋皮下,24小时后随机分组给药,其中,将生理盐水作为对照组灌胃给药;CTX(环磷酰胺)组腹腔给药;水杨梅根药材的水提取物(未经过沉淀、调酸、大孔树脂吸附和萃取的水提浓缩液)和实施例3、6制备的水杨梅根抗肿瘤提取物均为灌胃给药,于第11天称重处死小鼠取瘤块,称瘤重和测瘤体积,计算抑瘤率。Methods: Take the S180 tumor mass of the mouse, dilute it after homogenization and adjust the cell number (1×10 7 /ml), inject 0.2ml into the right axillary subcutaneous of the mouse, and randomly divide into groups for administration after 24 hours. Control group intragastric administration; CTX (cyclophosphamide) group intraperitoneal administration; the water extract (water extraction concentrate that has not been through precipitation, acid adjustment, macroporous resin adsorption and extraction) and embodiment 3 6. All the anti-tumor extracts prepared in 6 were intragastrically administered. On the 11th day, the mice were weighed and sacrificed to take tumor pieces, the tumor weight and volume were measured, and the tumor inhibition rate was calculated.
结果:水杨梅根药材的水提取物对S180抑瘤率为38.3%,而等剂量的本发明制备的水杨梅根抗肿瘤提取物的抑瘤率为66.4%,与对照组有显著差异,而与CTX组的差异不显著,提示它具有良好的抗肿瘤作用。结果见附表2。Result: the antitumor rate of S180 by the water extract of the root of the salicymus root medicinal material is 38.3%, and the antitumor rate of the antitumor extract of the root of the salicymus root prepared by the present invention is 66.4%, which is significantly different from that of the control group, while The difference with the CTX group was not significant, suggesting that it has a good anti-tumor effect. The results are shown in Table 2.
附表2水杨梅根有效部位对S180肉瘤的抑制动物实验Attached Table 2 Animal Experiments on the Inhibition of S180 Sarcoma by Effective Fractions of Salicymus Root
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100326651A CN100546601C (en) | 2005-01-04 | 2005-01-04 | Anti-tumor extract of salicymus root and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100326651A CN100546601C (en) | 2005-01-04 | 2005-01-04 | Anti-tumor extract of salicymus root and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1679795A true CN1679795A (en) | 2005-10-12 |
CN100546601C CN100546601C (en) | 2009-10-07 |
Family
ID=35066801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100326651A Expired - Fee Related CN100546601C (en) | 2005-01-04 | 2005-01-04 | Anti-tumor extract of salicymus root and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100546601C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100340251C (en) * | 2006-03-09 | 2007-10-03 | 中国林业科学研究院林产化学工业研究所 | Method for extracting anti-oxygenation active material from Chinese waxmyrtle Bark |
CN100383525C (en) * | 2005-12-02 | 2008-04-23 | 云南白药集团股份有限公司 | Identification method of bayberry root medicinal materials |
CN100383522C (en) * | 2005-12-02 | 2008-04-23 | 云南白药集团股份有限公司 | Determination method of bayberry root medicinal material |
CN103520651A (en) * | 2013-10-25 | 2014-01-22 | 刘瑾 | Traditional Chinese medicine composition for treating cervical cancer |
CN111686085A (en) * | 2020-06-30 | 2020-09-22 | 贵州益佰女子大药厂有限责任公司 | Preparation method of throat-clearing preparation |
-
2005
- 2005-01-04 CN CNB2005100326651A patent/CN100546601C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100383525C (en) * | 2005-12-02 | 2008-04-23 | 云南白药集团股份有限公司 | Identification method of bayberry root medicinal materials |
CN100383522C (en) * | 2005-12-02 | 2008-04-23 | 云南白药集团股份有限公司 | Determination method of bayberry root medicinal material |
CN100340251C (en) * | 2006-03-09 | 2007-10-03 | 中国林业科学研究院林产化学工业研究所 | Method for extracting anti-oxygenation active material from Chinese waxmyrtle Bark |
CN103520651A (en) * | 2013-10-25 | 2014-01-22 | 刘瑾 | Traditional Chinese medicine composition for treating cervical cancer |
CN111686085A (en) * | 2020-06-30 | 2020-09-22 | 贵州益佰女子大药厂有限责任公司 | Preparation method of throat-clearing preparation |
CN111686085B (en) * | 2020-06-30 | 2022-09-06 | 贵州益佰女子大药厂有限责任公司 | Preparation method of throat clearing preparation |
Also Published As
Publication number | Publication date |
---|---|
CN100546601C (en) | 2009-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105294623B (en) | A sesquiterpene lactone compound, its preparation method and application | |
CN102772500B (en) | Relingqing Polygonum capitatum Buch-Ham ex D.Don raw material extract with anti-inflammatory action | |
CN103877133B (en) | The extracting method at a kind of crocodile mouth flower active anticancer position and application | |
CN1392167A (en) | Preparing process and use of ginkgo leaf polypentenol and ginkgo leaf extract | |
CN1116894C (en) | Medicine for treating cardiovascular disease and preparation process thereof | |
CN1899491A (en) | Method for preparing paris polyphylla total saponin and its use | |
CN100408594C (en) | Active total saponin extract of Lonicerae argentina and its preparation method and application | |
CN104382968B (en) | Extraction method of andrographolide, andrographolide pharmaceutical composition and application | |
CN1679795A (en) | Anti-tumor extract of salicymus root and its preparation method and use | |
CN113773409B (en) | Polysaccharides from Scutellaria saponifera and its application | |
CN1141101C (en) | Chinese medicine for treating hepatitis B and its preparing process | |
CN102070573B (en) | Mono-tetrahydrofuran type sugar apple lactone compound with anti-tumor activity and application thereof | |
CN101396373A (en) | Cinobufacini extract and preparation method thereof | |
CN1679797A (en) | Anti-tumor extract of vine pear root and its preparation method and application | |
CN100436443C (en) | Compound (2S)-5, 7.2', 6'-tetrahydroxy-6,8-diiso pentenyl-dihydro flavone extracting process and its use | |
CN108129542A (en) | C-3,28,29- tri- replaces oleanane triterpene saponin and its pharmaceutical composition | |
CN101428049B (en) | Upper respiratory tract infection resistant medicament composition, preparation and uses thereof | |
CN1446818A (en) | Technique of preparing extract product of Radde Anemone Rhizome extract, and its application in preparing medication of treating cancer | |
CN115010618A (en) | A kind of uric acid-lowering golden amide alcohol ester separation and purification method and application thereof | |
CN1537849A (en) | Hydroxy stilbene kind compound and its preparation method and application | |
CN100577176C (en) | Extractive of Chinese globeflower in short petal, effective content of anti inflammation and usage | |
CN1775267A (en) | A kind of open arrow extract and its preparation method and application | |
CN1679796A (en) | Anti-tumor compound Polygonum cuspidatum root, Tengli root, Salicylica root preparation and its preparation method and application | |
CN1839926A (en) | Medicine for treating acute and chronic pharyngitis, tumour, and the rabdosia extraction method | |
CN100341888C (en) | Anticancer new compound of Xiacaogan I, preparation method, and application in pharmacy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091007 Termination date: 20120104 |